What Patients & Families Need to Know | New Visitor Policy | Guidance for Community Healthcare Providers
Assistant Professor, UC Department of PediatricsAssociate Professor, Department of Regenerative Medicine, Yokohama City University, Japan
Dr. Takebe is an assistant professor at the Cincinnati Children’s Hospital Medical Center. His lab is developing and applying mini-organ technologies from human stem cells – namely organ bud transplants – in patients with a rare congenital metabolic disorder, ultimately expanding the clinical applications to diseases like liver cirrhosis. Also, he holds a joint appointment at the Department of Regenerative Medicine, Yokohama City University in Japan, where he directs a translational program of human induced pluripotent stem cell (iPSC) based liver bud based approach for congenital liver disorders by developing a cGMP manufacturing platform.
Dr. Takebe successfully administered more than six nationally funded projects, awarded number of prestigious awards such as NYSCF robertson investigator award, and produced high impact peer-reviewed publications from each project. His recent associate professor appointment, at the age 26, was one of the youngest recorded in Japan.
Organoid; organogenesis; stem cell biology; transplantation; drug development
Visit the Takebe Lab.
Gastroenterology GI, Gastroenterology, Developmental Biology
Takanori Takebe, MD9/25/2019
Takanori Takebe, MD7/3/2019
Aaron M. Zorn, PhD, James M. Wells, PhD, Takanori Takebe, MD6/30/2019
De Novo-Designed Near-Infrared Nanoaggregates for Super-Resolution Monitoring of Lysosomes in Cells, in Whole Organoids, and in Vivo.
Fang, H; Yao, S; Chen, Q; Liu, C; Cai, Y; Geng, S; Bai, Y; Tian, Z; Zacharias, AL; Takebe, T; et al.
The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts.
Liu, T; Zhou, L; Yang, K; Iwasawa, K; Kadekaro, AL; Takebe, T; Andl, T; Zhang, Y.
Signal Transduction and Targeted Therapy.
Modelling human hepato-biliary-pancreatic organogenesis from the foregut–midgut boundary.
Koike, H; Iwasawa, K; Ouchi, R; Maezawa, M; Giesbrecht, K; Saiki, N; Ferguson, A; Kimura, M; Thompson, WL; Wells, JM; et al.
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.
Ouchi, R; Togo, S; Kimura, M; Shinozawa, T; Koido, M; Koike, H; Thompson, W; Karns, RA; Mayhew, CN; McGrath, PS; et al.
Organoids by design.
Takebe, T; Wells, JM.
Approach for Communication Design for Motivation to Health Behavior.
Iizuka, S; Takebe, T; Nishii, S; Kodaka, A.
Springer International Publishing.
Defining Lineage-Specific Membrane Fluidity Signatures that Regulate Adhesion Kinetics.
Matsuzaki, T; Matsumoto, S; Kasai, T; Yoshizawa, E; Okamoto, S; Yoshikawa, HY; Taniguchi, H; Takebe, T.
Stem Cell Reports.
Tumoroid a la carte: Path for personalization.
Lewis, K; Takebe, T.
Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells.
Nie, Y; Zheng, Y; Miyakawa, K; Murata, S; Zhang, R; Sekine, K; Ueno, Y; Takebe, T; Wakita, T; Ryo, A; et al.
Optimal Hypoxia Regulates Human iPSC-Derived Liver Bud Differentiation through Intercellular TGFB Signaling.
Ayabe, H; Anada, T; Kamoya, T; Sato, T; Kimura, M; Yoshizawa, E; Kikuchi, S; Ueno, Y; Sekine, K; Camp, JG; et al.
Stem Cell Reports.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2020 Cincinnati Children's Hospital Medical Center. All rights reserved.